Have a personal or library account? Click to login
Reorganisation of Oncologic Care in Greece: A Proposal Cover

Reorganisation of Oncologic Care in Greece: A Proposal

Forum of Clinical Oncology
Volume 6 (2015): Issue 4 (December 2015)
By: Christos Emmanouilides  
Open Access
|Mar 2016

References

  1. [1] COLLIER R. Drug development cost estimates hard to swallow. Canadian Med Assoc J, 2009, 180:279-28010.1503/cmaj.082040
    Search in Google Scholar
  2. [2] DIMASI JA, GRABOWSKI HG. Economics of new oncology drug development. J Clin Oncol 2007, 25:209-21610.1200/JCO.2006.09.0803
    Search in Google Scholar
  3. [3] ΚΑΡΑΜΠΛΗ Ε, ΧΑΤΖΑΚΗ Α, ΠΟΛΥΖΟΣ Ν, ΣΟΥΛΙΩΤΗΣ Κ, ΚΥΡΙΟΠΟΥΛΟΣ Γ. Η επίδραση της τεχνολογικής αλλαγής στη διαχρονική εξέλιξη της δαπάνης υγείας. Αρχ Ελλην Ιατρ 2014, 31:77-84
    Search in Google Scholar
  4. [4] WHO-International Agency for Research on Cancer. http://eco.iarc.fr/EUCAN/Country.aspx?ISOCountryCd=300
    Search in Google Scholar
  5. [5] Εθνικό σχέδιο δράσης για τον καρκίνο 2011-2015. Υπουργείο Υγείας και Κοινωνικών Ασφαλίσεων. http://www.anticancer.gov.gr/catalogue/SxedioDrasis_24selido.pdf
    Search in Google Scholar
  6. [6] MEROPOL NJ, SCHULMAN KA. Cost of cancer care:issues and implications. J Clin Oncol 2007, 25:180-18610.1200/JCO.2006.09.6081
    Search in Google Scholar
  7. [7] MARIOTTO AB, YABROFF KR, SHAO Y, FEUER EJ, BROWN ML. Projection of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011, 103:117-12810.1093/jnci/djq495
    Search in Google Scholar
  8. [8] SULLIVAN R, PEPPERCORN J, SIKORA K, ZALCBERG J, MEROPOL NJ, AMIR E ET AL. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011, 12:993-98010.1016/S1470-2045(11)70141-3
    Search in Google Scholar
  9. [9] AGGRAWAL A. Affordability of cancer care in the UK-Is it time to introduce user changes? J Cancer Policy 2014, 2:31-3910.1016/j.jcpo.2013.11.001
    Search in Google Scholar
  10. [10] LANG HC. Willingness to pay for lung cancer treatment. Value in Health. Journal of the International Society for Pharmacoeconomics and Outcomes Research 2010, 13:743–74910.1111/j.1524-4733.2010.00743.x20561327
    Search in Google Scholar
  11. [11] WONG YN, HAMILTON O, EGELSTON B, SALADOR K, MURPHY C, MEROPOL NJ. Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices. Oncologist 2010, 15:566–57610.1634/theoncologist.2009-0307289255620495218
    Search in Google Scholar
  12. [12] CHEVREUL K, DURAND-ZALESKI I, BAHRAMI SB, HERNANDEZ-QUEVEDO C, MLADOVSKY P. France Health System Review. Health Syst Trans 2010, 12:1-291
    Search in Google Scholar
  13. [13] TΟΥΝΤΑΣ Γ. O σχεδιασμός των υπηρεσιών υγείας. Αρχ Ελλην Ιατρ 2006, 23:72-83
    Search in Google Scholar
  14. [14] ΣΟΥΛΙΩΤΗΣ Κ, ΑΘΑΝΑΣΑΚΗΣ Κ, ΓΚΟΛΝΑ Χ, ΠΑΠΑΔΟΠΟΥΛΟΥ Χ, ΚΥΡΙΟΠΟΥΛΟΣ Γ. Περιφερική προσέγγιση των δομών για την φροντίδα των ογκολογικών ασθενών στην Ελλάδα. Αρχ Ελλην Ιατρ 2009, 26:808-817
    Search in Google Scholar
  15. [15] ΣΟΥΛΙΏΤΗΣ Κ. Μια (επαναλαμβανόμενη) πρόταση για την αναμόρφωση της πολιτικής φαρμάκου στην Ελλάδa. Αρχ Ελλην Ιατρ 2013, 5:519-521
    Search in Google Scholar
DOI: https://doi.org/10.1515/fco-2015-0018 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 28 - 34
Submitted on: Nov 5, 2015
|
Accepted on: Jan 14, 2016
|
Published on: Mar 31, 2016
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Oncology,
National Health System,
Health Services
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2016 Christos Emmanouilides, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 6 (2015): Issue 4 (December 2015)